Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin cream plus doxycycline MR versus ivermectin cream plus placebo for severe rosacea
2017-000157-40Phase 3Completed
- Sponsor
- Galderma
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rosacea comparing Soolantra + Oracea with Soolantra + placebo (2 arms). Primary endpoint: Percent change from baseline in inflammatory lesion count. Started May 2017; status: completed.
02
Drugs
ivermectindoxycycline
03
Conditions
rosacea
Beyond the preview
Go deeper on 2017-000157-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000157-40.